Bafetinib |
Inhibitor of ABL1, LYN
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
More...
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| ABL1 |
|
|
| LYN |
|
|
10 nM - 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC 50 - 19 nM
Potency Assay Off-Target:
Kinase Profiler assay
Selectivity Assessment Description:
79 kinases tested at 0.1 uM, Bafetinib inhibited ABL, ARG, FYN, and LYN; at 1.0 uM, Bafetinib inhibi ...
In Cell Selectivity Assessment
Selectivity Assessment Description:
The activity was detected in cells on PDGFR and KIT, but not EGFR.
Potency Cellular
In Vitro
ABL1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1182/blood-2005-06-2209
LYN
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1182/blood-2005-06-2209
In Vivo Validations
Mouse
Dose: 30 mg/kg
Route of delivery:
Oral
Plasma half life:
1 h
Organ of interest (O):
xenograft
DOI Reference: 10.1182/blood-2005-06-2209
Chemical Information
| Molecular Formula | C30H31F3N8O |
| SMILEs | Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1 |
| InChI | InChI=1S/C30H31F3N8O/c1-19-4-7-23(13-27(19)39-29-36-10-8-26(38-29)22-14-34-18-35-15-22)37-28(42)20-5-6-21(25(12-20)30(31,32)33)16-41-11-9-24(17-41)40(2)3/h4-8,10,12-15,18,24H,9,11,16-17H2,1-3H3,(H,37,42)(H,36,38,39)/t24-/m0/s1 |
| Molecular weight | 576.26 Da |
| AlogP | 5.392620000000004 |
| HBond acceptors | 9 |
| HBond donors | 2 |
| Atoms | 73 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the Portal.